TransMedics Group Financials - Benzinga

TransMedics Group Inc

TMDXNASDAQ

Trade with Public

Trade with Public

$84.96

-0.90-1.04%

Ult. Agg.: Sep 15, 8:32 AM

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzoDati finanziariSentiment Azionariato Confronta Opzioni Rapporto azionario

TransMedics Group Financials

TransMedics Group (TMDX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
TransMedics Group Appoints Fernando Araujo CFO, Effective Sept. 21; Reaffirms FY26 Revenue Range $737M - $757M

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), the global leader in portable warm perfusion for donor organs for transplantation, today announced the appointment of Fernando Araujo as Chief Financial

Benzinga Newsdesk

PRO
TransMedics Group Raises FY2026 Sales Guidance from $727.000M-$757.000M to $737.000M-$757.000M vs $732.700M Est

TransMedics Group (NASDAQ:TMDX) raises FY2026 sales outlook from $727.000 million-$757.000 million to $737.000 million-$757.000 million vs $732.700 million estimate.

Benzinga Newsdesk

PRO
TransMedics Gr Q2 Adj. EPS $0.44 Misses $0.47 Estimate, Sales $189.948M Beat $183.635M Estimate

TransMedics Gr (NASDAQ:TMDX) reported quarterly earnings of $0.44 per share which missed the analyst consensus estimate of $0.47 by 6.38 percent. This is a 52.17 percent decrease over earnings of $0.92 per share from

Benzinga Newsdesk

PRO
TransMedics Group Affirms FY2026 Sales Guidance of $727.000M-$757.000M vs $737.825M Est

TransMedics Group (NASDAQ:TMDX) affirms FY2026 sales outlook from $727.000 million-$757.000 million to $727.000 million-$757.000 million vs $737.825 million estimate.

Benzinga Newsdesk

PRO
TransMedics Gr Q1 Adj. EPS $0.30 Misses $0.61 Estimate, Sales $173.933M Beat $172.636M Estimate

TransMedics Gr (NASDAQ:TMDX) reported quarterly earnings of $0.30 per share which missed the analyst consensus estimate of $0.61 by 50.82 percent. This is a 59.46 percent decrease over earnings of $0.74 per share from

Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

© 2026 Benzinga | All Rights Reserved